REFOSCO, FIORENZO
 Distribuzione geografica
Continente #
AS - Asia 3.189
NA - Nord America 1.517
SA - Sud America 620
EU - Europa 516
AF - Africa 56
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.906
Nazione #
US - Stati Uniti d'America 1.426
SG - Singapore 1.361
CN - Cina 708
BR - Brasile 497
VN - Vietnam 333
HK - Hong Kong 324
FR - Francia 193
KR - Corea 160
IT - Italia 74
BD - Bangladesh 73
NL - Olanda 65
IN - India 53
CA - Canada 46
GB - Regno Unito 43
JP - Giappone 40
AR - Argentina 39
DE - Germania 30
ID - Indonesia 28
IL - Israele 20
CO - Colombia 18
EC - Ecuador 17
FI - Finlandia 16
MX - Messico 14
IQ - Iraq 13
RU - Federazione Russa 13
PL - Polonia 12
VE - Venezuela 12
TN - Tunisia 11
CL - Cile 10
JM - Giamaica 9
PE - Perù 9
UY - Uruguay 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
PH - Filippine 8
PK - Pakistan 8
SA - Arabia Saudita 8
UA - Ucraina 8
ES - Italia 7
GR - Grecia 7
PY - Paraguay 7
BE - Belgio 6
EG - Egitto 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
MA - Marocco 5
TR - Turchia 5
AT - Austria 4
BG - Bulgaria 4
CR - Costa Rica 4
KG - Kirghizistan 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
IE - Irlanda 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
RO - Romania 3
SE - Svezia 3
SN - Senegal 3
AU - Australia 2
BO - Bolivia 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
LT - Lituania 2
LU - Lussemburgo 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
Totale 5.896
Città #
Singapore 804
Santa Clara 494
Hefei 336
Hong Kong 321
San Jose 254
Seoul 159
Lauterbourg 154
Ho Chi Minh City 106
Beijing 92
Ashburn 88
Hanoi 84
Los Angeles 54
Dallas 40
Guangzhou 38
São Paulo 38
New York 19
Minamishinagawa 17
Rio de Janeiro 17
Tokyo 17
Haiphong 15
Brasília 14
Buffalo 14
Belo Horizonte 13
Bengaluru 13
Da Nang 12
Helsinki 12
Toronto 12
Frankfurt am Main 11
London 11
Orem 10
Biên Hòa 9
Hải Dương 9
Milan 9
Phoenix 9
Warsaw 9
Boardman 8
Brooklyn 8
Can Tho 8
Tashkent 8
City of London 7
Curitiba 7
Lima 7
Montreal 7
Amsterdam 6
Asunción 6
Brussels 6
Campinas 6
Fortaleza 6
Manaus 6
Montevideo 6
Naples 6
New Delhi 6
Shanghai 6
Thái Nguyên 6
Athens 5
Baku 5
Chennai 5
Chicago 5
Goiânia 5
Guayaquil 5
Ha Long 5
Nairobi 5
Newark 5
Ninh Bình 5
Philadelphia 5
Poços de Caldas 5
Riyadh 5
Rome 5
Salvador 5
Taboão da Serra 5
Uberlândia 5
Bauru 4
Belém 4
Casablanca 4
Contagem 4
Guarulhos 4
Hyderabad 4
Moscow 4
Ottawa 4
Phủ Lý 4
Porto Alegre 4
Quito 4
Recife 4
Santiago 4
Abidjan 3
Addis Ababa 3
Amman 3
Apucarana 3
Aracaju 3
Auckland 3
Baghdad 3
Berlin 3
Bishkek 3
Bologna 3
Boston 3
Bình Dương 3
Cairo 3
Camaçari 3
Campo Grande 3
Canoas 3
Totale 3.625
Nome #
Voltammetric behaviour of rhenium(I) complexes with phosphine and carbon monoxide ligands in acetonitrile solvent 80
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 79
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 75
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 74
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 72
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 71
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 69
Monooxorhenium(V) complexes with the tridentate Schiff base N-(2-hydroxyphenyl)salicylideneimine 66
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 66
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 63
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 63
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 58
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 58
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 56
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 53
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 53
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 53
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 52
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 52
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 51
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 50
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 50
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 49
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 49
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 48
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 48
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 46
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 46
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 46
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 46
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 45
Radioactive Transition Metal Nitride Hetero-Complex 45
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 45
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 45
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 45
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 44
Syntheses and characterisation of rhenium-(III) and -(V) complexes containing aminophosphine ligands. Crystal structures of [Re-V(OCl2)(OMe)L] and [Re-III(Cl3L)(PPh3)], L equals o-(diphenylphosphino)-N,N'-dimethylaniline 44
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 43
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 43
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 43
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 43
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 43
Synthesis and characterization of technetium(V) oxo-complexes with quadridentate Schiff-base ligands: X-ray structures of ?-oxo-bis-{oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)] technetium(V)} and chloro-oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)]-technetium(V) 42
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 41
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 41
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 41
Low-Valent Technetium Complexes with Aminodiphosphines 40
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 40
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 40
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 39
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 39
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 38
The (Tc(N)(PNP))(2+) metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies 38
Synthesis and characterization of a new series of asymmetrical M(III) (M = Re, 99gTc) complexes of the type [MIII(PS)2(L)], where PS = phosphinothiolate; L = dithiocarbamate (DTCn) or pyridine-2-thiolate (MPy) - Synthesis and characterization of novel asy 37
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 36
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 36
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 36
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 36
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 36
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 35
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 35
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 35
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 35
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 34
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 34
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 34
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 34
Synthetic routes to mono-N-functionalized P2N2-ligands 33
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 32
Alternative Synthesis of Aminodiphosphines 32
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 31
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 31
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 31
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 31
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 31
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 31
The [Tc(N)PNP]2+ metal fragment labeled Cholecystokinin-8 (CCK8) peptide for CCK2 receptors imaging: preliminary biological studies 31
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 31
The relationship between the electrospray ionization behaviour and biological activity of some phosphino Cu(I) complexes 31
Mixed ligand Tc-and Re-nitrido complexes for radiolabelling bioactive molecules 30
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 30
Design and Synthesis Of Tc- And Re-Based Metal-Fragments 30
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 30
SYNTHESIS AND CHARACTERIZATION OF TECHNETIUM(V) AND RHENIUM(V) OXO-COMPLEXES WITH SCHIFF-BASE LIGANDS CONTAINING THE ONN DONOR-ATOM SET - MOLECULAR-STRUCTURE OF TRANS-DICHLORO-OXO[1-(8'-QUINOLYLIMINOMETHYL)-2-NAPHTHOLATO-NN'O]TECHNETIUM(V) 30
Synthesis of a series of Cu(I) derivatives containing PTA, PTAH and mPTA ligands and evaluation of their cytotoxic activity 30
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 29
A library of cysteine-biotine derivatives useful for pretargeting avidin-biotin radioimmunoscintigraphy 29
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP=heterodiphosphane) 29
Neutral and cationic nickel (II) complexes of phosphino-amines: [NiCl2(PMe2Ph)(PNMe2)] and [NiCl(PMe2Ph) (PNMe2)]PF6 (PNMe2 = N,N?-dimethyl-2-(diphenylphosphino) aniline) 28
Copper(I) and copper(II) complexes of polydentate phosphinoamines 28
Cytotoxicity and mitochondrial disfunction induced by copper(I) complexes with tris(cyanoethyl)phosphine or tris(carboxyethyl)phosphine 28
SYNTHESIS AND CHARACTERIZATION OF NEUTRAL TECHNETIUM(III) COMPLEXES WITH MIXED S,P-BIDENTATE PHOSPHINE THIOLATE LIGANDS - CRYSTAL-STRUCTURE OF [TC(SCH2CH2PPH2)2(SCH2CH2PPH2O)] 28
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = bisphosphinoamine). 28
99mTc-nitrido complexes with a library of cysteine-biotin derivatives for pretargeting avidin-biotin immunoscintigraphy 28
[Tc-99m(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 28
Crystal structures of neutral trigonal bipyramidal [NiCl2(PMePh2)(PNMe2)]center dot 1/2CH(2)Cl(2) and cationic square planar [NiCl(PMePh2)(PNMe2)][PF6] complexes 27
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 27
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 27
UNUSUAL SYNTHESIS AND X-RAY STRUCTURE OF CIS-DICHLORO[1,2-BIS(O-(DIPHENYLPHOSPHINO)PHENYL)ETHANE-1,2-DIOLATO(2-)]TECHNETIUM(IV) HEMIETHANOL SOLVATE 27
Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [Tc-99m(N)(PNP)](2+) metal fragment 27
Totale 4.176
Categoria #
all - tutte 23.586
article - articoli 14.523
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 290
Totale 38.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202457 0 0 0 0 0 0 0 0 2 0 53 2
2024/20252.149 16 12 184 93 418 94 20 86 25 59 599 543
2025/20263.554 200 331 392 599 578 130 511 175 151 176 81 230
2026/2027146 146 0 0 0 0 0 0 0 0 0 0 0
Totale 5.906